AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Joe Rojas-Burke
Oct. 16--Oregon achieved savings of more than $400,000 a month by steering Oregon Health Plan patients to lower-cost brands of prescription drugs, according to a study by researchers at Oregon State University's college of pharmacy.
But those savings melted away after drug-industry lobbyists persuaded Oregon lawmakers to stop the state from enforcing the preferred drug list in 2003.
The study, published in the current issue of the journal Health Affairs, sheds light on the behind-the-scenes battle between drug makers and states trying to control health spending.
Oregon's "evidence-based" drug list gained legislative approval in July 2001. In preparing the list, panels of doctors and pharmacists compare the effectiveness of ...
Source: HighBeam Research, State finds, loses big savings on low-cost drugs.